China wafer-fab equipment market and semiconductor-equipment localization Report Interpretation

Overview

This industry report argues that China’s WFE market is entering a more memory-intensive expansion phase. Morgan Stanley expects robust spending through 2028 and sees tighter export controls as a near-term execution risk that may ultimately strengthen localization opportunities for domestic equipment vendors.

Core views

Morgan Stanley forecasts China WFE spending of US$45.6bn in 2026, US$55.8bn in 2027 and US$68.6bn in 2028, corresponding to growth of 9%, 23% and 23%. China is expected to account for 28%, 25% and 27% of global WFE in those years. The report estimates nearly US$23bn of incremental China WFE spending from 2026 to 2028 as investment shifts from mature-node construction toward memory and more advanced process technologies. Memory is expected to drive much of the 2027 acceleration, while advanced-node logic capacity additions could add another source of demand in 2028 across deposition, etch and cleaning equipment. The memory-capex case rests on continued expansion by CXMT and YMTC. Morgan Stanley forecasts CXMT additions of 100kwpm in each of 2026, 2027 and 2028, with total 12-inch capacity rising from 180kwpm in 2025 to 500kwpm in 2028. It sees Hefei as the central expansion base; a potential deferral of the Lingang project would shift timing and location rather than change medium-term expansion ambitions. For YMTC, the report forecasts additions of 35kwpm, 100kwpm and 100kwpm in 2026, 2027 and 2028. Its planned Rmb33bn fundraising includes Rmb20.8bn for mass-production-line technology upgrades, which Morgan Stanley views as additional evidence for sustained WFE intensity beyond greenfield capacity projects. The proposed MATCH Act is framed as a two-sided development. The bill could impose countrywide licensing requirements with a presumption of denial for chokepoint tools, including DUV immersion lithography, TSV deposition and etch, cryogenic etch and cobalt deposition, and extend restrictions to servicing, installation, calibration, software, training and technical support. It could cover facilities operated by SMIC, Hua Hong, Huawei, CXMT and YMTC. Morgan Stanley considers this a near-term risk to fab ramp schedules because critical foreign tools remain difficult to replace. However, with domestic WFE localization estimated at only about 25% in 2026, the report argues that tighter controls could increase urgency around qualifying domestic etch, deposition and cleaning tools, accelerating local-vendor share gains over the medium term. Morgan Stanley remains Overweight on NAURA, AMEC and ACMR. NAURA is identified as the preferred broad-based localization beneficiary because of its exposure to deposition, etch and thermal processing. Its target is reduced to Rmb788 from Rmb818 after 2026/27/28 EPS cuts of 14%, 5% and 6%, respectively. Revenue estimates are lowered 2%, 0% and 1% due mainly to component-procurement delivery delays in 2Q26, while heavier R&D assumptions reduce operating leverage. Revised EPS is Rmb10.93, Rmb17.71 and Rmb22.27. The base case assumes a 30% 2025-28 revenue CAGR, gradual domestic-share gains and modest gross-margin expansion; the bull case assumes revenue CAGR above 45%, market-share gains and gross margin above 45% in 2026, while the bear case assumes revenue CAGR below 15%, flat-to-lower share and gross margin below 35%. For ACMR, Morgan Stanley remains positive on China WFE demand, stronger-than-expected share gains and the longer-term expansion of ECP, PECVD and track tools. It maintains revenue forecasts of US$1.17bn, US$1.54bn and US$1.86bn for 2026-28, but cuts 2027 and 2028 EPS by 11% and 4% as higher R&D for PECVD and track platforms lowers projected operating margins to 17.7% and 20.6%, from 19.0% and 21.7%. The target price is reduced to US$115 from US$130. The base case assumes 27% revenue CAGR in 2025-28 and 2026 gross margin of 45.6%; downside would involve order cancellations, slower China share gains, revenue growth below 5%, gross margin below 40%, or more restrictive U.S. measures. AMEC is presented as a key memory-foundry and localization beneficiary, supported by orders from advanced-node and memory customers, expanding product lines and its entry into CMP through the SiZone Tech acquisition. Morgan Stanley raises 2026/27/28 revenue estimates by 1%, 12% and 12% on stronger memory-foundry expansion, and raises operating-margin forecasts to 14.0%, 20.8% and 23.2%. EPS nevertheless falls 13%, 10% and 12% to Rmb6.07, Rmb7.00 and Rmb9.20 because of the share split. The price target is lowered to Rmb428 from Rmb488, largely reflecting that split. Its base case assumes steady local-equipment demand, expected shipment growth in leading-edge and memory equipment, and a 39.9% 2026 margin; weaker semiconductor demand, slower customer ramps and pricing pressure are the principal downside conditions.

Analysis framework

Morgan Stanley first sizes China WFE demand using spending forecasts and memory-fab capacity plans, then assesses how export-control risks affect both fab execution and domestic-tool qualification. It applies this industry view to NAURA, ACMR and AMEC through revenue, margin, R&D and earnings revisions, and derives company price targets using residual-income models with explicit discount-rate, growth and payout assumptions.

Methodology notes

• Industry AnalysisSupply-demand framework

  China WFE market sizing based on fab-capacity additions, memory investment and localization demand.

  The report links planned DRAM and NAND capacity growth, technology migration and local-tool qualification to demand for WFE equipment.

• Valuation methodsRIM (Residual Income Model)

  Residual income valuation for NAURA, ACMR and AMEC.

  The models value expected returns above the cost of equity using assumptions for WACC or cost of equity, medium-term growth, terminal growth and, for ACMR and AMEC, dividend payout.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• NAURA Technology Group Co Ltd (002371.SZ)

  Preferred broad-based beneficiary of China semiconductor-equipment localization.

  Strengths

  Exposure across deposition, etch and thermal processing; expected benefit from high Chinese logic and memory-fab capex; 17.9% KingSemi stake may complement its portfolio.

  Weaknesses

  Higher R&D investment and component-procurement delivery delays reduce near-term operating leverage.

  Comparison

  Morgan Stanley identifies NAURA as its preferred broad-based localization beneficiary.

  Risks

  Slower fab expansion, weaker R&D and cost reduction versus peers, share loss, gross margin below 35%, and weaker customer capex.

• ACM Research Inc (ACMR.O)

  Beneficiary of Chinese foundry and memory demand, with potential share gains in ECP and non-cleaning tools.

  Strengths

  Long-term US$4.0bn revenue target, stronger-than-expected share gains, and new PECVD and track-product opportunities.

  Weaknesses

  Higher R&D for PECVD and track platforms lowers near-term operating leverage.

  Comparison

  Its ECP is positioned as a potential advanced-packaging enabler, including with customers outside mainland China.

  Risks

  Order cancellations, slower share gains, weaker China demand, gross margin below 40%, and additional U.S. restrictions affecting operations.

• Advanced Micro-Fabrication Equipment Inc (688012.SS)

  Key beneficiary of memory-foundry expansion and Chinese demand for localized etch and deposition equipment.

  Strengths

  Advanced-node and memory orders, expansion into EPI and process control, and entry into CMP through SiZone Tech.

  Weaknesses

  Heavy R&D spending and valuation changes associated with the share split.

  Comparison

  The report highlights AMEC's structural position in Chinese semiconductor equipment and its exposure to memory localization.

  Risks

  Weak semiconductor demand, slower product development, slower Chinese customer ramps and pricing pressure from major fab customers.

Key data

• China WFE TAMUS$45.6bn / US$55.8bn / US$68.6bnMorgan Stanley forecast for 2026/2027/2028; 9%/23%/23% year-on-year growth.
• Domestic WFE localization rate~25%Morgan Stanley estimate for 2026; a basis for its localization-upside argument.
• CXMT annual capacity additions100kwpm in 2026, 2027 and 2028Forecast capacity additions; total 12-inch capacity is projected to reach 500kwpm by 2028.
• YMTC planned fundraisingRmb33bn, including Rmb20.8bn for mass-production-line upgradesThe report views this as support for sustained equipment investment.
• NAURA price targetRmb788Reduced from Rmb818 after revised earnings assumptions.
• ACMR price targetUS$115Reduced from US$130 after higher R&D assumptions.
• AMEC price targetRmb428Reduced from Rmb488, mostly reflecting the share split.

Impact & implications

Morgan Stanley expects continued memory investment and localization to sustain demand for Chinese WFE suppliers, particularly in etch, deposition and cleaning. Tighter controls could disrupt near-term fab schedules, but the report believes they could also speed domestic qualification and local-vendor share gains.

Risks

• The proposed MATCH Act could constrain equipment access and delay memory and advanced-node fab ramp schedules.
• CXMT Lingang expansion could be deferred, changing the timing and location of capacity additions.
• NAURA faces component-procurement delays, heavier R&D costs, potential share loss and customer-capex weakness.
• ACMR faces potential order cancellations, slower China share gains, margin pressure and further U.S. restrictions.
• AMEC faces weaker semiconductor demand, slower local capacity expansion, slower product development and pricing competition.

What to watch

• China WFE spending growth and the scale of memory-led investment in 2027 and 2028.
• CXMT capacity ramps, the timing of Lingang versus Hefei expansion, and progress in advanced DRAM products.
• YMTC's IPO process, fundraising deployment and Fab 3, Fab 4 and Fab 5 capacity ramps.
• Legislative progress on the MATCH Act and any expansion of multilateral export controls.
• Domestic qualification and market-share progress for etch, deposition, cleaning, ECP, PECVD, track, EPI and CMP tools.
• R&D spending, delivery execution, margins and earnings revisions at NAURA, ACMR and AMEC.